Iovance Biotherapeutics
IOVA
IOVA
236 hedge funds and large institutions have $1.71B invested in Iovance Biotherapeutics in 2022 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 101 increasing their positions, 70 reducing their positions, and 50 closing their positions.
Holders
236
Holders Change
-12
Holders Change %
-4.84%
% of All Funds
3.99%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.07%
New
41
Increased
101
Reduced
70
Closed
50
Calls
$32.1M
Puts
$18.1M
Net Calls
+$14M
Net Calls Change
-$20.3M
Top Buyers
| 1 |
1
State Street
Boston,
Massachusetts
|
$130M |
| 2 |
2
BlackRock
New York
|
$128M |
| 3 |
3
Citadel Advisors
Miami,
Florida
|
$27.8M |
| 4 |
4
D.E. Shaw & Co
New York
|
$22.9M |
| 5 |
5
Goldman Sachs
New York
|
$21.6M |
